Composite endpoints for detecting meaningful changes in trials of headache treatments
- 14 March 2013
- journal article
- letter
- Published by SAGE Publications in Cephalalgia
- Vol. 33 (7) , 499
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Detecting meaningful changes in trials of headache treatments: Which outcome measure is best?Cephalalgia, 2012
- Total Migraine Freedom, a Potential Primary Endpoint to Assess Acute Treatment in Migraine: Comparison to the Current FDA Requirement Using the Complete Rizatriptan Study DatabaseHeadache: The Journal of Head and Face Pain, 2010
- Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: Application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptanCephalalgia, 2010
- Use of the Sustained Pain-Free Plus No Adverse Events Endpoint in Clinical Trials of Triptans in Acute MigraineCNS Drugs, 2007